Literature DB >> 14625238

Severe tacrolimus leukoencephalopathy after liver transplantation.

Janneke Schuuring1, Pieter Wesseling, Aad Verrips.   

Abstract

Tacrolimus is an immunosuppressive agent that can show a wide variety of neurologic side effects, including leukoencephalopathy. Although the prognosis is good-after cessation or dose reduction, complete recovery usually occurs-the differentiation with treatable diseases such as progressive multifocal encephalopathy can be difficult, making a stereotactic biopsy of the white matter lesion sometimes necessary. We describe the case of a 12-year-old girl with a severe, reversible tacrolimus-related leukoencephalopathy and only mild histopathologic abnormalities.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625238      PMCID: PMC8148927     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  8 in total

1.  FK506-induced leukoencephalopathy in children with organ transplants.

Authors:  H V Torocsik; R G Curless; J Post; A G Tzakis; L Pearse
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

Review 2.  Immunosuppressive-associated leukoencephalopathy in organ transplant recipients.

Authors:  N Singh; A Bonham; M Fukui
Journal:  Transplantation       Date:  2000-02-27       Impact factor: 4.939

3.  The reversible posterior cerebral edema syndrome.

Authors:  W P Dillon; H Rowley
Journal:  AJNR Am J Neuroradiol       Date:  1998-03       Impact factor: 3.825

4.  Transient MR signal changes in patients with generalized tonicoclonic seizure or status epilepticus: periictal diffusion-weighted imaging.

Authors:  J A Kim; J I Chung; P H Yoon; D I Kim; T S Chung; E J Kim; E K Jeong
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

5.  Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506)

Authors:  S L Small; M B Fukui; G T Bramblett; B H Eidelman
Journal:  Ann Neurol       Date:  1996-10       Impact factor: 10.422

6.  Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells.

Authors:  S Kochi; H Takanaga; H Matsuo; M Naito; T Tsuruo; Y Sawada
Journal:  Eur J Pharmacol       Date:  1999-05-21       Impact factor: 4.432

7.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

8.  FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.

Authors:  S V McDiarmid; R W Busuttil; N L Ascher; J Burdick; A M D'Alessandro; C Esquivel; M Kalayoglu; A S Klein; J W Marsh; C M Miller
Journal:  Transplantation       Date:  1995-02-27       Impact factor: 4.939

  8 in total
  7 in total

1.  Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.

Authors:  Samuel Singer; Christian Grommes; Anne S Reiner; Marc K Rosenblum; Lisa M DeAngelis
Journal:  Oncologist       Date:  2015-06-01

2.  Progressive necrotic encephalopathy following tacrolimus therapy for liver transplantation.

Authors:  Paolo Aridon; Paolo Ragonese; Norma Di Benedetto; Giovanni Grasso; Pier Giulio Conaldi; Marco D'Amelio; Giovanni Savettieri
Journal:  Neurol Sci       Date:  2009-09-25       Impact factor: 3.307

3.  Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression.

Authors:  C Horbinski; W S Bartynski; E Carson-Walter; R L Hamilton; H P Tan; S Cheng
Journal:  AJNR Am J Neuroradiol       Date:  2008-10-14       Impact factor: 3.825

4.  Posterior reversible encephalopathy syndrome: the importance of early diagnosis.

Authors:  Rute Teotónio; Dina Marmoto; Cristina Januário; Conceição Bento
Journal:  BMJ Case Rep       Date:  2012-09-17

5.  Tacrolimus for Remission Induction and Maintenance Therapy in Patients with Ulcerative Colitis: A Retrospective Evaluation Study.

Authors:  Ayumi Ito; Bunei Iizuka; Teppei Omori; Shinichi Nakamura; Katsutoshi Tokushige
Journal:  Gastroenterol Res Pract       Date:  2016-06-16       Impact factor: 2.260

6.  Nfat/calcineurin signaling promotes oligodendrocyte differentiation and myelination by transcription factor network tuning.

Authors:  Matthias Weider; Laura Julia Starost; Katharina Groll; Melanie Küspert; Elisabeth Sock; Miriam Wedel; Franziska Fröb; Christian Schmitt; Tina Baroti; Anna C Hartwig; Simone Hillgärtner; Sandra Piefke; Tanja Fadler; Marc Ehrlich; Corinna Ehlert; Martin Stehling; Stefanie Albrecht; Ammar Jabali; Hans R Schöler; Jürgen Winkler; Tanja Kuhlmann; Michael Wegner
Journal:  Nat Commun       Date:  2018-03-02       Impact factor: 14.919

7.  Cyclosporine-induced Leukoencephalopathy Precipitated Following Interaction with Ciprofloxacin.

Authors:  Divya Nagabushana; Supraja Chandrasekhar; Stalin Ramprakash; Gurudutt Avathi Venkatesha; Rajesh V Helavar
Journal:  J Pediatr Neurosci       Date:  2021-07-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.